Paxman AB (publ) (PAX.ST)
- Previous Close
72.20 - Open
72.60 - Bid 71.40 x --
- Ask 71.60 x --
- Day's Range
71.20 - 72.60 - 52 Week Range
39.90 - 81.60 - Volume
3,211 - Avg. Volume
43,742 - Market Cap (intraday)
1.497B - Beta (5Y Monthly) 0.37
- PE Ratio (TTM)
63.36 - EPS (TTM)
1.13 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
116.00
Paxman AB (publ), together with its subsidiaries, develops and sells Paxman scalp cooling system to minimize hair loss in connection with chemotherapy treatment worldwide. It serves various cancer centers and hospitals. The company has collaborated with the University of Huddersfield and the University of Leeds to utilize state-of-the-art technological advances to develop a wearable medical cooling device, and the National University Hospital of Singapore for the development of a cooling and compression system. Paxman AB (publ) was founded in 1996 and is headquartered in Karlshamn, Sweden.
paxmanscalpcooling.comRecent News: PAX.ST
View MorePerformance Overview: PAX.ST
Trailing total returns as of 5/21/2025, which may include dividends or other distributions. Benchmark is OMX Stockholm 30 Index (^OMX) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: PAX.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: PAX.ST
View MoreValuation Measures
Market Cap
1.51B
Enterprise Value
1.37B
Trailing P/E
63.89
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.28
Price/Book (mrq)
5.47
Enterprise Value/Revenue
5.23
Enterprise Value/EBITDA
23.76
Financial Highlights
Profitability and Income Statement
Profit Margin
15.27%
Return on Assets (ttm)
10.62%
Return on Equity (ttm)
28.05%
Revenue (ttm)
263.2M
Net Income Avi to Common (ttm)
40.2M
Diluted EPS (ttm)
1.13
Balance Sheet and Cash Flow
Total Cash (mrq)
40.31M
Total Debt/Equity (mrq)
8.72%
Levered Free Cash Flow (ttm)
1.26M